Trials / Unknown
UnknownNCT04917003
Safety and Efficacy of Remote Ischemic Conditioning Combined EDAS on Ischemic Moyamoya Disease
Safety and Efficacy of Remote Ischemic Conditioning Combined Encephaloduroarteriosynangiosis(EDAS)on Ischemic Moyamoya Disease: A Prospective, Randomized, Controlled Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Capital Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Encephaloduroarteriosynangiosis (EDAS) is widely used as an indirect technique for treatment of moyamoya disease. Nevertheless, this indirect surgery tends to establish insufficient collateral circulation in most adult MMD patients. Nowadays, there is a lack of adjuvant therapies for improving collateral circulation induced by indirect revascularization. This study aims to explore whether remote ischemic conditioning can improve the collateral circulation after indirect revascularization.
Detailed description
Encephaloduroarteriosynangiosis (EDAS) is widely used as an indirect technique for treatment of moyamoya disease. Nevertheless, this indirect surgery tends to establish insufficient collateral circulation in most adult MMD patients. Nowadays, there is a lack of adjuvant therapies for improving collateral circulation induced by indirect revascularization. Remote ischemic conditioning (RIC) is a noninvasive approach protecting the brain by inflating and deflating blood-pressure cuff placed on the upper limbs. It has been confirmed to improve cerebral perfusion by promoting angiogenesis and arteriogenesis in ischemic animal brain. In addition, daily remote ischemic conditioning is a promising technique to ameliorate chronic cerebrovascular disease like intracranial atherosclerotic stenosis, small-vessel disease. Thus, this study aims to explore whether remote ischemic conditioning can improve the collateral circulation after indirect revascularization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | RIC plus EDAS | Patients who are allocated into RIC group will undergo EDAS surgery combined 3-month RIC treatment. The opposite operation will be performed at 3 months after the first operation. |
| OTHER | EDAS | Patients who are allocated into the control group will accept EDAS surgery twice. The second operation will be performed at 3 months after the first operation. |
Timeline
- Start date
- 2021-06-15
- Primary completion
- 2022-06-30
- Completion
- 2022-06-30
- First posted
- 2021-06-08
- Last updated
- 2021-06-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04917003. Inclusion in this directory is not an endorsement.